TEVA CANADA LTD v. PFIZER CANADA INC ET AL
Summary of A-283-17
The following information was obtained from the Federal Court or Federal Court of Appeal websites but is NOT the official version. See links below for the court websites.
Federal Court Type: Appeal (S.27 - Final) - Patent Act
Detected Type: Statutory Appeal - Others [from T-1399-15 - S. 18.1 Patented Medicines (Notice of Compliance) Regulations]
Parties and Lawyers:| Party | Firm | Lawyer |
|---|---|---|
| MINISTER OF HEALTH (THE) | ||
| PFIZER CANADA INC | ||
| TEVA CANADA LIMITED | AITKEN KLEE LLP | NORRIE, BRYAN |
| WYETH LLC |
| Name | Number |
|---|---|
| 668 PATENT | 2436668 |
Patented Medicine: Desvenlafaxine (Medicinal ingredients are based on automated analysis and should not be relied upon.)
Decisions
| Name | Date | Paragraph |
| Teva Canada Limited v. Pfizer Canada Inc. 2019 FCA 15 | Jan 25, 2019 | On August 22, 2017, following proceedings under the Patented Medicines (Notice of Compliance) Regulations, Brown J. of the Federal Court issued an order as part of his judgment (2017 FC 777) prohibiting the Minister of Health from issuing a NOC to Teva in respect of a NOA sent by Teva to Pfizer until the expiry of Canadian Patent No. 2,436,668. The ‘668 Patent concerns a drug called O-desmethyl-venlafaxine (ODV). It is used for the treatment of depression. This appeal relates to Form I ODV succinate which is a particular crystal form of a particular salt of ODV, namely ODV succinate. Teva appeals the Federal Court Judge’s decision. This appeal, along with the companion appeal in Apotex Inc. v. Pfizer Canada Inc. et al. (2019 FCA 16), concern issues related to the Federal Court Judge’s obviousness analysis in respect of the ‘668 Patent. ... In essence, Teva argues that the Federal Court Judge misconstrued and misapplied the test for obviousness as set out in Apotex Inc. v. Sanofi-Synthelabo Canada Inc., 2008 SCC 61 and that his obviousness analysis is directly contrary to two judgments rendered by our Court: Bristol-Myers Squibb Canada Co. v. Teva Canada Limited, 2017 FCA 76; and Pfizer Limited v. Ratiopharm Inc., 2010 FCA 204. Teva also argues that the Federal Court Judge made palpable and overriding errors in considering the properties in his reasons because they are not part of the inventive concept and that he further erred in accepting hearsay evidence and misunderstanding the evidence particularly as it relates to the work conducted by Wyeth. For the reasons below, I would dismiss the appeal with costs. |
This is an appeal from 2017 FC 777 in T-1399-15. [Determination of the appeal is based on automated analysis and should not be relied upon.]
Docket Summary (Google Translate to English)
(31) 2021-07-14 - OttawaTraduction certifiée conforme en français du jugement / doc. # 28 rendu(e)(s) le 25-JAN-2019 déposée le 14-JUL-2021 inscrit(e) dans le livre J. & O., volume 317 page(s) 291 - 291
Traduction certifiée conforme en français des motifs publics du jugement rendu(e)(s) le 25-JAN-2019 déposée le 01-FEV-2019
Memorandum to file from the Registry of the FCA dated 11-FEB-2019 trnasmitting a copy of the Judgment and Reasons for Judgment to Justice Brown and the Applications section of the FC. placed on file.
Acknowledgment of Receipt received from all parties (by email) with respect to the Public Reasons for Judgment placed on file on 07-FEB-2019
Reasons for Judgment (Public version) rendered by The Honourable Mr. Justice Boivin concurred in by The Honourable Mr. Justice Webb The Honourable Mr. Justice de Montigny dated 25-JAN-2019 The Court's decision is with regard to Appeal received on 01-FEB-2019
Letter from the respondent dated 30-JAN-2019 noting that the corporate parties do not assert any confidentiality in the reasons and as such, they may be released without any redactions. received on 30-JAN-2019
Memorandum to file from the FCA Registry dated 30-JAN-2019 On Friday, January 25, 2018, the Registry inadvertently sent the confidential Reasons for Judgment in files A-283-17 and A-288-17 by email to all parties in both appeals. Thereafter, the Registry contacted counsel for the appellants in both files; they confirmed that copies of the Reasons for Judgment not related to their own proceeding would be destroyed, and that the contents thereof would not be disclosed. placed on file.
Acknowledgment of Receipt received from all the parties by email with respect to docs. 28-29 placed on file on 28-JAN-2019
Reasons for Judgment (Confidential) rendered by The Honourable Mr. Justice Boivin concurred in by The Honourable Mr. Justice Webb The Honourable Mr. Justice de Montigny dated 25-JAN-2019 The Court's decision is with regard to Appeal Filed on 25-JAN-2019
Judgment dated 25-JAN-2019 rendered by The Honourable Mr. Justice Webb The Honourable Mr. Justice Boivin The Honourable Mr. Justice de Montigny Matter considered with personal appearance The Court's decision is with regard to Appeal Result: dismissed Filed on 25-JAN-2019 entered in J. & O. Book, volume 305 page(s) 64 - 64 (Final decision)
****** CANCELLED ****** Sealed envelope pursuant to the Order of the Court dated 18-APR-2016 on behalf of the Court (Webb, Boivin and de Montigny JJ.A.) purporting to contain the Confidential Judgment and Reasons for Judgment of the Court dated 25-JAN-2019 Filed on 25-JAN-2019
This matter comes on for hearing on 19-NOV-2018 at Ottawa before The Honourable Mr. Justice Webb The Honourable Mr. Justice Boivin The Honourable Mr. Justice de Montigny Appearances: Mr. Bryan Norrie, Mr. David Aitken and Mr. Aleem Abdulla 613-903-5107 for the appellant Mr. Andrew Shaughnessy, Mr. Andrew Bernstein, Ms. Nicole Mantini and Ms. Rachel Saab 416-865-8171 for Pfizer Canada Inc. and Wyeth LLC Language of Hearing: E Court Usher: Pierre Gendron Duration: on 19-NOV-2018 from 09:30 to 03:00 Courtroom : West Courtroom - Supreme Court of Canada Court Registrar Jean-François Duport Total duration: 5 hours 30 minutes Before the Court: appeal Result: reserved Comments: Hearing mostly confidential. Confidential compendium and outline of arguments and additional authorities submitted by the respondents Minutes of Hearing entered in Vol. 228 page(s) 187 - 193 Abstract of Hearing placed on file
Solicitor's certificate of service on behalf of Aleem Abdulla confirming service of ID 52 and books of authorities upon Applicant by courier on 18-OCT-2018 filed on 18-OCT-2018
Covering letter from Applicant dated 18-OCT-2018 concerning ID 52 and joint book of authorities placed on file on 18-OCT-2018
Joint Book of Authorities consisting of 3 volume(s) on behalf of Applicant Filed on 18-OCT-2018 3 copy(ies) for the Court stored in Ottawa
Sealed envelope pursuant to Order dated December 7, 2015 on behalf of Applicant purporting to contain volumes 1 and 2 of the Plaintiff's Compendium Received on 18-OCT-2018
Memorandum to file from E. Rabouin / Registry Assistant dated 12-OCT-2018 3 copies of the Public and confidential USB Keys (ID. 29 & 30) have been sent to the Judge. Pursuant to the Appellant's letter dated October 12, 2018 (ID 50), the 2 additional USB Keys have been put with ID 28 & 29 as the Orignal copy and extra copy. placed on file.
Letter from the appellant dated 12-OCT-2018 further to the phone conversation requesting additional copies of the Appeal Book documents, please find enclosed 2 additional USB keys containing sealed envelopes containing USB keys with confidential versions of the same materials received on 12-OCT-2018
Acknowledgements of receipt of an electronic copy of the hearing date order, e-mailed to: Mr. Norrie, solicitor for Teva Canada Ltd., Ms. Mantini, solicitor for Pfizer Canada Inc. and Wyeth LLC, and Mr. Teza Lwin, solicitor for the Minister of Health placed on file on 10-OCT-2018
Order (time and place) dated 03-OCT-2018 rendered by D. Lanteigne, Judicial Administrator and signed by Judicial Administrator fixing Appeal to be heard at Special Sitting in Ottawa on 19-NOV-2018 to begin at 09:30 Filed on 03-OCT-2018 cc's sent to parties entered in J. & O. Book, volume 304 page(s) 4 - 4 Transmittal letters placed on file
Letter from the respondent dated 12-JUN-2018 enclosing a CD containing requested documents. received on 13-JUN-2018
Covering letter from Appellant dated 07-JUN-2018 concerning the enclosed CD containing the Appellant's Memorandum of Fact and Law and other documents requested by the Court, placed on file on 08-JUN-2018
Letter from the respondent dated 12-APR-2018 in respect of the scheduling of the hearings for the present appeal and the Appeal in A-288-17. received on 12-APR-2018
Communication from Registry to Judicial Administrator dated 11-APR-2018 re: fixing date and place for hearing
Covering letter from Appellant dated 09-APR-2018 concerning Doc. Nos. 22 23 placed on file on 09-APR-2018
Solicitor's certificate of service on behalf of Aleem Abdulla confirming service of the Requisition for Hearing upon the Respondents by telecopier on 09-APR-2018 filed on 09-APR-2018
Requisition for hearing - Appeal from Appellant filed on 09-APR-2018
Solicitor's certificate of service on behalf of Nicole Mantini confirming service of doc. #20 upon Appellant Respondent by e-mail and Courier on 20-MAR-2018 filed on 21-MAR-2018
PUBLIC VERSION of Memorandum of Fact & Law on behalf of the Respondent Pfizer Canada Inc. filed on 21-MAR-2018
Consent to extension of time to file Doc 17 on behalf of the parties filed on 19-MAR-2018
Solicitor's certificate of service on behalf of Nicole Mantini confirming service of Doc 17 upon Appellant by email and overnight courier on 19-MAR-2018 confirming service Doc 17 upon Respondent by same-day courier on 19-MAR-2018 filed on 19-MAR-2018
Sealed envelope pursuant to Order dated 07-DEC-2015 in T-1399-15 on behalf of Pfizer Canada Inc and Wyeth LLC, Respondent purporting to contain Confidential Memorandum of Fact and Law Filed on 19-MAR-2018
Solicitor's certificate of service on behalf of Aleem Abdulla confirming service of doc 14 & 15 upon Respondent by hand on 02-FEB-2018 filed on 02-FEB-2018
PUBLIC VERSION Memorandum of Fact & Law on behalf of the appellant filed on 02-FEB-2018 3 judges' copies stored in Ottawa
Sealed envelope pursuant to Order dated 7-DEC-2015 T-1399-15 on behalf of Appellant purporting to contain Memorandum of Fact & Law 3 Judge's Copies stored in Ottawa Filed on 02-FEB-2018
Consent to extension of time for service & filing of A's Memo on behalf of all parties filed on 02-FEB-2018
Covering letter from Appellant dated 01-DEC-2017 concerning Doc. Nos. 10 11 placed on file on 01-DEC-2017
Envelope, containing three USB keys containing public version of appeal documents permitted to be filed electronically per order dated 01-Dec-2017 on behalf of the Appellant placed on file on 07-DEC-2017
Sealed envelope pursuant to order of Wood JA dated 01-Dec-2017 (3 envelopes) on behalf of Appellant purporting to contain confidential version of Appeal Book documents permitted to be filed electronically. Received on 07-DEC-2017
Letter from the appellant dated 07-DEC-2017 further to directions of Woods JA dated 01-Dec-2017 and phone conversation enclosed please find 3 USB keys containing public versions of the materials to be filed electronically and 3 sealed envelopes containing USB keys with confidential versions of the same materials. received on 07-DEC-2017
Acknowledgment of Receipt received from all parties (by email) with respect to the Direction of the Court dated December 1, 2017 placed on file on 04-DEC-2017
Letter from the appellant dated 01-DEC-2017 in response to the Court Direction ID.24 received on 04-DEC-2017
Solicitor's certificate of service on behalf of Aleem Abdulla confirming service of doc.s #10 & 11 upon Respondent by electronic copy on CD by courier on 30-NOV-2017 filed on 01-DEC-2017
Written directions of the Court: The Honourable Madam Justice Woods dated 01-DEC-2017 directing " The appellant has requested permission to file the appeal book in electronic format pursuant to Rule 345(2)(b). The respondent Pfizer Canada Inc. and Wyeth LLC have consented to the request. By pratice direction of the Chief Justice dated February 12, 2015, this provision is not yet in force. The parties are directed to: (1) file the appeal book in paper format, except for documents related to the proceeding below as described in Rule 344(1)(e) which may be filed in electronic format by USB Memory stick; and (2) file the documents referred to in their memorandum of fact and law in paper format." received on 01-DEC-2017
Appeal Book consisting of 16 volume(s) prepared by the appellant filed on 01-DEC-2017 3 judges' copies stored in Ottawa
CONFIDENTIAL Appeal Book consisting of 16 volume(s) including confidential volume(s) 1 2 3 4 5 6 7 8 9 10 13 14 15 16 prepared by the appellant filed on 01-DEC-2017 3 judges' copies stored in Ottawa
Communication from Registry to Judicial Administrator dated 27-NOV-2017 re: Letter from Appellant dated Nov 16, 2017 re: filing of appeal book in electronic format
Letter from the appellant dated 16-NOV-2017 requesting a Direction from the Court to whether the Appeal Book can be filed on a CD or USB received on 16-NOV-2017
Covering letter from Appellant dated 01-NOV-2017 concerning Doc. Nos. 8 9 placed on file on 01-NOV-2017
Solicitor's certificate of service on behalf of Aleem Abdulla confirming service of document No. 8 upon Respondent by telecopier on 01-NOV-2017 filed on 01-NOV-2017
Agreement as to the content of the Appeal book from the appellant filed on 01-NOV-2017
Memorandum to file from E. Rabouin / Registry Assistant dated 30-OCT-2017 the working copy of the Notice of Appeal (confidential) has been place in the VA annex further to the Direction of the Court dated October 27, 2017. placed on file.
Acknowledgment of Service received from all parties (by email) with respect to the Direction of the Court dated October 27, 2017 placed on file on 30-OCT-2017
Written directions of the Court: The Honourable Madam Justice Gauthier dated 27-OCT-2017 directing " Please immediately replace the Notice of Appeal originally received on October 2, 2017 by the public version of the Notice of Appeal received on October 12, 2017. The confidential version of the Notice of Appeal should be treated as confidential in accordance with the Order dated December 7, 2015 in file T-1399-15." received on 30-OCT-2017
Memorandum to file from Ottawa, FCA Registry dated 16-OCT-2017 I called the Appellant, in regards to his letter dated October 12, 2017 on ID.10. Said Letter talks about the consent of the all other parties regarding the request of having a confidential and a public version of the Notice of Appeal. However the Registry did not receive on that time any consent from the other parties. The Appellant confirmed that he will submit to the Registry of the Consent of all parties to his said letter. placed on file.
Communication from Registry to Judicial Administrator dated 24-OCT-2017 re: letter ID for confidentiality
Letter from the appellant with consent of all parties dated 20-OCT-2017 "... Please find enclosed a copy of an e-mail from counsel for Pfizer Canada Inc. and Wyeth LLC (together, "Pfizer) providing the consent referred to in our letter dated October 12, 2017..." "...Please also find enclosed a copy of an e-mail from counsel for the Minister of Health providing consent to the materials filed on October 12, 2017..." received on 20-OCT-2017
Letter from the appellant dated 12-OCT-2017 The Appellant, with Respondent's consent, notes the Notice of Appeal issued on 02-Oct-2017 makes reference to informtion considered to be confidential and under seal in file T-1399-15. Counsel request that Issued Notice of Appeal be treated as confidential. Enclosed are envelopes to seal the Issued Appeal. Counsel requests the enclosed Public Notice of Appeal be accepted for filing and enclose a Working copy of the Issued Notice of Appeal which highlights the portions of the Issued Notice of Appeal that are redacted in the Pulbic Notice of Appael. received on 12-OCT-2017
Solicitor's certificate of service on behalf of Nicole Mantini confirming service of Doc#6 Notice of Application upon Appellant and Respondent (Minister of Health) by telecopier on 05-OCT-2017 filed on 05-OCT-2017
Notice of appearance on behalf of Respondent (Respondents (Pfizer Canada Inc. and Wyeth LLC) filed on 05-OCT-2017
Affidavit of James Adeney on behalf of The Respondent - The Minister of Health sworn on 03-OCT-2017 confirming service of Doc. # 4 on the appellant Respondents, Pfizer Canada and Wyeth LLC by telecopier on 03-OCT-2017 with attached exhibit(s) A filed on 03-OCT-2017
Notice of appearance on behalf of The Respondent - The Minister of Health filed on 03-OCT-2017
Copy of document 1 with proof of service on the respondent on 03-OCT-2017 filed on 03-OCT-2017
Covering letter from Appellant dated 02-OCT-2017 concerning Doc. No. 2 placed on file on 02-OCT-2017
Affidavit of Dawn Trach on behalf of the appellant sworn on 02-OCT-2017 confirming service of Doc. no.1 on the respondent by telecopier on 02-OCT-2017 filed on 02-OCT-2017
Memorandum to file from the Registry of the FCA dated 02-OCT-2017 transmitting a copy of the Notice of Appeal to Justice Brown and the Applications section of the FC. placed on file.
Notice of Appeal and 2 copies filed on 02-OCT-2017 against a decision of the Federal Court of Appeal from a Judgment of Brown, J. dated 22-Aug-17 re: Court file T-1399-15 **Amended Public version* Confidential in VA** Certified copy(ies)/copy(ies) transmitted to Deputy Attorney General of Canada Tariff fee of $50.00 received: yes
The official version of the court proceeding information is available from the court websites directly: